• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:童国新,李晓春,王宁夫,来蕾,冷建杭.甲基莲心碱对人脐静脉血管平滑肌细胞增殖及表型调节的影响[J].中国现代应用药学,2011,28(5):387-390.
TONG Guoxin,LI Xiaochun,WANG Ningfu,LAI Lei,LENG Jianhang.Effect of Neferine on the Proliferation and Phenotype of Human Umbilical Vein Smooth Muscle Cells[J].Chin J Mod Appl Pharm(中国现代应用药学),2011,28(5):387-390.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2524次   下载 2856 本文二维码信息
码上扫一扫!
分享到: 微信 更多
甲基莲心碱对人脐静脉血管平滑肌细胞增殖及表型调节的影响
童国新1, 李晓春2, 王宁夫1, 来蕾1, 冷建杭1
1.杭州市第一人民医院心内科,南京医科大学附属杭州医院,杭州310006;2.浙江大学医学院附属第二医院干部科,杭州310006
摘要:
目的 研究甲基莲心碱对人脐静脉平滑肌细胞增殖及表型调节的影响。方法 以0.1,0.5,1.0,5.0 μmol·L-1甲基莲心碱处理平滑肌细胞,采用MTT 法和流式细胞术观察甲基莲心碱对人脐静脉血管平滑肌细胞增殖的影响。用免疫印迹法检测收缩型平滑肌细胞特异性标志物SM1,calponin 1和α-actin蛋白的表达。结果 甲基莲心碱(0.1~5.0 μmol·L-1)处理12,24,48 h后,人脐静脉血管平滑肌细胞的增殖具有明显的抑制作用,并具有剂量依赖关系和时间依赖关系。在缺乏甲基莲心碱的干预下,血管平滑肌细胞SM1,calponin 1和α-actin蛋白表达减少,在用0.5,5.0 μmol·L-1甲基莲心碱处理48 h后,可显著逆转SM1,calponin 1和α-actin蛋白表达的减少,且具有剂量依赖性。结论 甲基莲心碱具有抑制血管平滑肌细胞增殖及表型转化的作用,可用于防治动脉粥样硬化和再狭窄。
关键词:  甲基莲心碱  平滑肌细胞  流式细胞术  增殖  表型
DOI:
分类号:
基金项目:浙江省中医药科技计划基金资助项目(2007CA112)
Effect of Neferine on the Proliferation and Phenotype of Human Umbilical Vein Smooth Muscle Cells
TONG Guoxin,LI Xiaochun,WANG Ningfu,LAI Lei,LENG Jianhang
Abstract:
OBJECTIVE To study the effect of neferine on the proliferation and phenotypic modulation of human umbilical vein smooth muscle cells (HUVSMCs) cultured in vitro. METHODS The effect of neferine(0.1, 0.5, 1.0, 5.0 μmol·L-1) on HUVSMCs proliferation was studied by using MTT colorimeter and flow cytometry. Western blotting was used to indicate the changes of protein levels of the contractile-phenotype smooth muscle specific markers, such as smooth muscle myosin heavy chain-1 (SM1), calponin 1 and α-actin. RESULTS Neferine could significantly decrease the cell numbers of HUVSMCs after treatment for 12, 24, 48 h, and the anti-proliferation effects were in a concentration-dependent and time-dependent manner when the concentrations of neferine were between 0.1 and 5.0 μmol·L-1. In the absence of neferine treatment, the protein levels of the smooth muscle specific markers (SM1, calponin 1 and α-actin) decreased during culture. However, the treatment of VSMCs with neferine (0.5 or 5.0 μmol·L-1) for 48 h reversed the effect in a concentration-related manner. CONCLUSION These data suggest that neferine may arrest the growth of VSMCs and inhibit phenotypic modulation, thereby preventing cell dedifferentiation. These properties of neferine suggest that the drug can provide useful therapy for atherosclerosis and restenosis.
Key words:  neferine  smooth muscle cell  flow cytometry  proliferation  phenotype
扫一扫关注本刊微信